TrialDiabetes & metabolism journal2021

Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study.

Seung-Hwan Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.